Kathleen Mitchell, MD
Obstetrics & Gynecology · Chattanooga, TNNPI 1528043841
Payments from drug & device makers
Across 89 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$234
- Astellas Pharma US Inc$216
- Sage Therapeutics, LLC$192
- Therapeuticsmd, Inc.$138
- Exeltis, USA Inc.$96
- Mayne Pharma Commercial LLC$86
- plus $563 from 16 others
What the payments were for
- Food & beverage$1,51499%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 14 | $234 |
| Astellas Pharma US Inc | 10 | $216 |
| Sage Therapeutics, LLC | 11 | $192 |
| Therapeuticsmd, Inc. | 9 | $138 |
| Exeltis, USA Inc. | 7 | $96 |
| Mayne Pharma Commercial LLC | 4 | $86 |
| Pfizer | 5 | $82 |
| Myovant Sciences Inc. | 4 | $73 |
| Avion Pharmaceuticals | 4 | $69 |
| Bayer | 3 | $59 |
| Daiichi Sankyo Inc. | 3 | $44 |
| Shield Therapeutics Inc | 2 | $36 |
| Coopersurgical, Inc. | 2 | $33 |
| Urovant Sciences Inc | 2 | $29 |
| Merck | 2 | $25 |
| Millicent US Inc | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Roche Diagnostics Corporation | 1 | $16 |
| Organon | 1 | $13 |
| Evofem Biosciences, Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,526 in reported general payments places this provider in the 60th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 70 | $4,035 |
| ValacyclovirValacyclovir Hcl | 48 | $3,120 |
| YuvafemEstradiol | 11 | $2,136 |
| Estradiol (Once Weekly)Estradiol | 13 | $853 |
| Clobetasol Propionate | 14 | $481 |
| Metronidazole | 29 | $464 |
| Alendronate Sodium | 38 | $318 |
| Acyclovir | 18 | $292 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $164 |
| Fluconazole | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Chattanooga
- Daniel HarnsbergerChattanooga$2.5M
- David BarkerChattanooga$446K
- Rayan ElkattahChattanooga$26K
- Kent ChildsChattanooga$23K
- Linda YuChattanooga$19K
- Gary BrunvollChattanooga$11K
- Shevonda SherrowChattanooga$9K
- Benjamin ChappellMemphis$1.2M
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.